The Hon’ble Supreme Court of India, in Dineshchand Surana v UCO Bank, 2026 INSC 579 (Surana), examined the interplay between the moratorium provisions under Part III of the IBC code and proceedings for dishonour of cheque under Section 138 of the NI Act.
Khaitan & Co advised IIFL Finance Ltd in relation to the update of its existing USD 1 billion Global Medium Term Note Programme (GMTN Programme) on the IFSC Gift City stock exchanges (India INX and NSE IX). The notes which will be issued under this GMTN Programme will be issued in compliance with Rule 144A and Regulation S of the U.S. Securities Act, 1933. The Hongkong and Shanghai Banking Corporation Ltd, J.P.
Khaitan & Co acted as lender’s legal counsel to Indian Railway Finance Corporation Ltd (“IRFC”) for financial assistance of ₹13,527 crores from IRFC to L&T Metro Rail (Hyderabad) Ltd for the purpose of inter alia refinancing of existing debt of the company in relation to setting up and implementation of the rail system for 71.16 km on elevated structures on Miyapur to L. B.
Khaitan & Co acted as the legal counsel to RDC Concrete (India) Ltd (“Issuer”) in relation to the issuance of senior, secured, rated, listed, taxable, transferable, redeemable, non-convertible debentures, for an aggregate amount of up to INR 75 Crores, including a green shoe option, on a private placement basis (“Issue”).
Khaitan & Co advised General Catalyst in relation to its investment in the series C round of Scapia Technology Pvt Ltd (“Scapia”) (lead by General Catalyst) for a total consideration of ~USD 63 million.
On 22 April 2026, RBI issued the Draft PPI Directions.
Khaitan & Co advised the consortium of Oberoi Realty Ltd, Shree Naman Developers Pvt Ltd and JM Financial Properties and Holdings Ltd on the implementation of the NCLT-approved resolution plan and acquisition of Hotel Horizon Pvt Ltd for a total consideration of INR 920 crores.
Khaitan & Co acted as a legal counsel for Jayaswal Neco Industries Ltd on the preferential issue of warrants to M/s Vibrant Enterprises, a member of the promoter group, for an aggregate amount of INR 200 crores, which is subject to requisite statutory and other approvals, as applicable.
Khaitan & Co is representing Amneal Pharmaceuticals, LLC (Amneal) as India counsels, alongside Simpson Thacher & Bartlett LLP in relation to its announced agreement to acquire 100% of Kashiv Biosciences LLC ("Kashiv"), a vertically integrated biopharmaceutical company incorporated in the United States of America, with 2 (two) subsidiaries in India (namely, Kashiv Biosciences Pvt Ltd and Kashiv Research Pvt Ltd), in a transaction with consideration that includes USD 375 million of cash and USD 375 mill
Khaitan & Co acted as the lead counsel to Federal Bank on the acquisition of a segment of Standard Chartered Bank’s Indian credit card portfolio. The Firm played a key role in structuring and executing the transaction, including undertaking legal due diligence on the portfolio, advising on complex legal and regulatory considerations, leading negotiations, and drafting and finalising the transaction documents.
